EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark MODAGIN was filed as Word mark on 04/03/2023 at the European Union Intellectual Property Office.
It was registered as a trademark on 05/08/2024.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018857542 |
| Application date | April 3, 2023 |
| Publication date | May 12, 2023 |
| Entry date | May 8, 2024 |
| Expiration date | April 3, 2033 |
Trademark owner
Mikroforum Ring 3
55234 Wendelsheim
DE
55234 Wendelsheim
DE
Trademark representatives
Prinzregentenplatz 15
81675 München
DE
Objection / Complaint
08/14/2023: Likelihood of confusion
Applicant
STADA Arzneimittel AG
goods and services
5
Medicines for human purposes; Medicines for veterinary purposes; Pharmaceuticals and natural remedies; Medicines, for use in the following fields: Treating Alzheimer's disease; Medicines, for use in the following fields: Treating neurodegenerative diseases; Chemico-pharmaceutical preparations; Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations and materials; Diagnostic biomarker reagents for medical purposes; Diagnostic reagents for medical use; Dragees [medicines]; Injectable pharmaceuticals; Medicinal preparations and substances; Antiparkinson agents; Pharmaceutical drugs; Pharmaceuticals; Pharmaceutical preparations for human use; Pharmaceutical preparations for the treatment of Parkinson's disease; Pharmaceutical preparations for use in the treatment of Alzheimer's disease; Pharmaceutical preparations for treating neurodegenerative diseases; Pharmaceutical preparations for the treatment of brain related disorders; Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; All the aforesaid goods solely relating to neurodegenerative illnesses including Alzheimer's and Parkinson's disease or relating to PET tracers for neurodegenerative illnesses; All the aforesaid goods excluding medicines for the treatment of cardiovascular and cerebrovascular diseases
42
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Consultancy relating to pharmaceutical research and development; Biological research; Clinical research and medical research; Medical research laboratory services; Technical tests, in relation to the following goods: drugs; Analysis of human serum for medical research; Analysis of human tissues for medical research; Development of pharmaceutical preparations and medicines; Pharmaceutical products development; Research and development of vaccines and medicines; Providing scientific information in the field of medical disorders and their treatment; Research in the field of pharmacogenetics; Research on the subject of pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Clinical research; Laboratory research services relating to pharmaceuticals; Medical research; Medical and pharmacological research services; Pharmaceutical drug development services; Pharmaceutical research services; Pharmaceutical research and development; Inspection of pharmaceuticals; Scientific research in the field of pharmacy; Scientific research and development; All the aforesaid services solely relating to neurodegenerative illnesses including Alzheimer's and Parkinson's disease or relating to PET tracers for neurodegenerative illnesses
44
Medication counseling; Providing information to patients in the field of administering medications; Provision of information relating to medicine; Advisory services relating to the treatment of degenerative diseases; Advisory services relating to medical services; Provision of pharmaceutical information; Advisory services relating to degenerative diseases; Consultancy and information services relating to pharmaceutical products; Consultancy and information services provided via the Internet relating to pharmaceutical products; Consultancy and information services relating to medical products; Advisory services relating to pharmaceuticals; Medical services; Health care services for treating Alzheimer's disease; Pharmaceutical services; Preparation and dispensing of medications; All the aforesaid services solely relating to neurodegenerative illnesses including Alzheimer's and Parkinson's disease or relating to PET tracers for neurodegenerative illnesses
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| June 19, 2024 | RAW: Trade mark - Partial Surrender, Registered |
ID: 11018857542